Immunofluorescent analysis of these xenograft tumors showed a co-staining of ALDH1A3 and CD44, which is a previously described CSC marker for HNSCC [19] (Figure 5C). The gene discussed is ALDH1A3; the disease is head and neck squamous cell carcinoma.